LongevityAlliance.eu unites the world's leading longevity clinics, researchers, and innovators to build the shared clinical standard, pooled evidence base, and collective voice the field has never had.
Longevity medicine is advancing faster than the infrastructure meant to validate it. Every leading clinic is generating outcome data — almost none of it ever leaves the building.
Pharmaceutical trials succeed in part because they pool patients, protocols, and outcomes across sites into datasets large enough to be statistically convincing to regulators and insurers. Longevity clinics, however sophisticated, have been working in isolation — each with its own protocol, its own outcome definitions, and a patient base too small to stand on its own.
The result: a field with genuine clinical promise, but without the shared evidence architecture that would let regulators reimburse it and insurers underwrite it the way they do a prescription.
Outcome data sits in individual EMRs, incompatible across clinics and unusable at scale.
Clinics define "biological age," "healthspan," and "response" differently — so results can't be compared.
Regulators and insurers have no single body to negotiate with, and no dataset large enough to evaluate.
Three commitments, undertaken jointly by every founding member, that none could achieve alone.
A common protocol and outcome-reporting framework, drafted and ratified by founding members, so results from one clinic mean the same thing at another.
A pooled, de-identified dataset spanning member organizations — built to reach the scale and rigor of pharmaceutical trial data over time.
A single coalition able to engage regulators and insurers directly, on behalf of every member, rather than each clinic negotiating alone.
Founding members join before the standard is written — and help write it. Membership carries four core rights.
Direct input into the Alliance's shared clinical standards and outcome-reporting framework from day one, not after it's finalized.
De-identified outcome data across member organizations, giving every clinic visibility into results at a scale no single site can produce alone.
Representation in the Alliance's advocacy with regulators and insurers, pressing the case for preventive care to be reimbursed like prescriptions.
First visibility into cross-border capital, partnership, and distribution opportunities surfaced through the Alliance network.
The founding roster is limited to organizations whose standing will shape the Alliance's protocols and priorities — not simply follow them.
A operating history in longevity, preventive, or precision medicine with documented patient outcomes.
Published research, active trials, or original protocol development in the field.
The systems in place, or in progress, to contribute de-identified outcome data to a shared base.
A willingness to adopt common protocol and reporting definitions alongside other founding members.
A short, direct process — designed to move quickly while the founding roster is still being formed.
Share your organization's clinical background, research output, and data capabilities through the founding application.
A working group of early founding members reviews each application against the Alliance's eligibility criteria.
Approved organizations are formally ratified as founding members and named on the founding roster.
Founding members are onboarded into the standards process, evidence base, and advocacy working groups.
Founding Membership closes once the roster reaches 100 organizations. After that, membership terms change — this invitation does not repeat.